Danirixin (GSK1325756)
CAS: 954126-98-8
Ref. 3D-ENB12698
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
Danirixin (GSK1325756)
Description:
Danirixin is a small molecule drug that has been shown to inhibit the activity of the chemokine CCL2. It has clinical relevance in chronic cough, cancer, and infectious diseases. Danirixin is an orally bioavailable small molecule that inhibits the activity of CCL2 and acts as a chemo-preventative agent against metastatic pancreatic cancer. This drug also has a novel mechanism of action and may be used in vivo to treat chronic bronchitis, chronic pulmonary diseases, and other inflammatory conditions. Danirixin demonstrates pharmacokinetic properties that make it suitable for use in humans with myeloid-derived suppressor cells.>>END>>
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
441.9 g/mol
Formula:
C19H21ClFN3O4S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
